Third Harmonic Bio, INC Form 4 insider transactions
Jennifer Dittman, Chief Development Operations Officer at Third Harmonic Bio, exercised stock options and sold shares on May 16, 2024, according to a Form 4 filing with the SEC.
Dennis Dean, Chief Nonclinical Development Officer of Third Harmonic Bio, Inc., acquired 210,000 employee stock options on May 16, 2024.
Third Harmonic Bio CEO Natalie Holles exercised stock options and sold shares on May 9, 2024, according to a Form 4 filing with the SEC.
Form 4: Third Harmonic Bio CEO Natalie Holles Executes Stock Option and Sells Shares Under 10b5-1 Plan
Third Harmonic Bio CEO Natalie Holles exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Julie Person, Chief Administrative Officer of Third Harmonic Bio, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.
Geoff McDonough, a director of Third Harmonic Bio, Inc., acquired 60,000 stock options on March 27, 2024, according to a Form 4 filing with the SEC.